- Home
- BJDX vs VERO Comparison
BJDX vs VERO Comparison
Compare BJDX & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BJDX
- VERO
- Stock Information
- Founded
- BJDX 2015
- VERO N/A
- Country
- BJDX United States
- VERO Canada
- Employees
- BJDX N/A
- VERO N/A
- Industry
- BJDX Medical Specialities
- VERO Medical/Dental Instruments
- Sector
- BJDX Health Care
- VERO Health Care
- Exchange
- BJDX Nasdaq
- VERO Nasdaq
- Market Cap
- BJDX 2.9M
- VERO 2.2M
- IPO Year
- BJDX 2021
- VERO N/A
- Fundamental
- Price
- BJDX $1.59
- VERO $2.43
- Analyst Decision
- BJDX
- VERO
- Analyst Count
- BJDX 0
- VERO 0
- Target Price
- BJDX N/A
- VERO N/A
- AVG Volume (30 Days)
- BJDX 77.3K
- VERO 55.7K
- Earning Date
- BJDX 05-13-2025
- VERO 05-15-2025
- Dividend Yield
- BJDX N/A
- VERO N/A
- EPS Growth
- BJDX N/A
- VERO N/A
- EPS
- BJDX N/A
- VERO N/A
- Revenue
- BJDX N/A
- VERO $60,997,000.00
- Revenue This Year
- BJDX N/A
- VERO N/A
- Revenue Next Year
- BJDX $55.56
- VERO $7.55
- P/E Ratio
- BJDX N/A
- VERO N/A
- Revenue Growth
- BJDX N/A
- VERO N/A
- 52 Week Low
- BJDX $1.46
- VERO $2.10
- 52 Week High
- BJDX $316.92
- VERO $17.49
- Technical
- Relative Strength Index (RSI)
- BJDX 38.85
- VERO 48.55
- Support Level
- BJDX $1.56
- VERO $2.11
- Resistance Level
- BJDX $1.92
- VERO $2.37
- Average True Range (ATR)
- BJDX 0.13
- VERO 0.14
- MACD
- BJDX 0.03
- VERO 0.04
- Stochastic Oscillator
- BJDX 7.73
- VERO 71.74
About BJDX Bluejay Diagnostics Inc.
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.